Skip to main content

Table 3 Operative data, postoperative complications and deaths of each groups in the training cohort

From: Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma

  Single segment-HCC (n = 151) Multiple segments-HCC (n = 60) Single segment vs Multiple segments (P-value)
Variables Left segment (n = 64) Middle segment (n = 28) Right segment (n = 58) Caudate area (n = 1)
Duration operation (min) 205.2 ± 83.8 201.4 ± 70.3 203.4 ± 84.3 620 241.0 ± 86.5 0.017
Blood loss (ml) 283.5 ± 356.8 336.0 ± 240.3 321.6 ± 312.1 300 411.8 ± 486.9 0.185
Blood transfusion       0.635
 Yes 7 (10.9%) 9 (32.1%) 10 (17.2%) 0 12 (20.0%)
 No 57 (89.1%) 19 (67.9%) 48 (82.8%) 1 (100.0%) 48 (80.0%)
Surgical margin (cm)       0.470
 < 1.0 20 (31.3%) 4 (14.3%) 9 (15.5%) 0 16 (22.7%)
 ≥ 1.0 44 (68.7%) 24 (85.7%) 49 (84.5%) 1 (100.0%) 44 (77.3%)
Overall complications 17 (26.6%) 7 (25.0%) 14 (17.2%) 0 (0%) 14 (23.3%) 0.781
 Wound infection (GradeI) 3 (4.7%) 1 (3.6%) 3 (5.2%) 0 (0%) 3 (5.0%)
 Ascites (GradeI) 9 (14.1%) 3 (10.7%) 8 (13.8%) 0 (0%) 6 (10.0%)
 Acute hepatic failure (GradeIV) 1 (1.6%) 0 (0%) 0 (0%) 0 (0%) 1 (1.7%)
 Pulmonary inflammation (GradeII) 3 (4.7%) 3 (10.7%) 3 (5.2%) 0 (0%) 4 (6.7%)
 Haemorrhage (Grade IV) 1 (1.6%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
In-hospital mortality 2 (3.1%) 0 (0%) 0 (0%) 0 (0%) 1 (1.7%) 0.850